ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2012
Treatment of obesity in children and adolescents.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 65 citations in OpenAlex.
- Evaluation of Physical Activity and Lifestyle Interventions Focused on School Children with Obesity Using Accelerometry: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020Pooled it
- Serious games as an educational strategy to control childhood obesity: a systematic literature review1.Revista latino-americana de enfermagem · 2018Pooled it
- Drug interventions for the treatment of obesity in children and adolescents.The Cochrane database of systematic reviews · 2016Pooled it
- Exercise and BMI in Overweight and Obese Children and Adolescents: A Systematic Review and Trial Sequential Meta-Analysis.BioMed research international · 2015Pooled it
- The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial.Journal of obesity · 2016Trial
- Overweight & obesity epidemic, temporal trends and regional disparities in physical growth of Vietnamese children.Scientific reports · 2026Article
- Benefits of Physical Activity on Cardiometabolic Diseases in Obese Children and Adolescents.Journal of translational internal medicine · 2022Article
- 2020 Korean Society for the Study of Obesity Guidelines for the Management of Obesity in Korea.Journal of obesity & metabolic syndrome · 2021Review
- Laparoscopic Sleeve Gastrectomy for Adolescents Under 18 Years Old with Severe Obesity.Obesity surgery · 2020Article
- Pharmacotherapy for the Treatment of Overweight and Obesity in Children, Adolescents, and Young Adults in a Large Health System in the US.Frontiers in endocrinology · 2020Article
- Effect ofSaudi journal of biological sciences · 2019Article
- ASMBS pediatric metabolic and bariatric surgery guidelines, 2018.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2018Review
- Effect of folic acid and metformin on insulin resistance and inflammatory factors of obese children and adolescents.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2016Article
- Obesity and type 2 diabetes in children: epidemiology and treatment.Current diabetes reports · 2014Review
- The therapy of insulin resistance in other diseases besides type 2 diabetes.Eating and weight disorders : EWD · 2014Review
- Zonisamide for weight loss in adolescents.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2013Article
- Evaluation of Body Mass Index (BMI) Percentile cut-off Levels with Reference to Insulin Resistance: A Comparative Study on South Indian Obese and Non-Obese Adolescents.Journal of clinical and diagnostic research : JCDR · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of childhood and adolescent obesity continues to rise in the United States (US). Immediate health consequences are being observed, and long-term risks are mounting within the pediatric population, secondary to obesity. The hallmark of prevention and treatment of obesity in children and adolescents includes lifestyle modification (i.e., dietary modification, increased physical activity, and behavioral modifications). However, when intensive lifestyle modification is insufficient to reach weight loss goals, adjunctive pharmacotherapy is recommended. Among the group of weight-loss medications, orlistat is the only US Food and Drug Administration (FDA)-approved prescription drug for the treatment of overweight and obese adolescents. Other medications, including metformin, need larger studies to establish their role in treatment. No single approach to management of pediatric obesity is the answer, given the complexity of the disorder and the many reasons for failure. Evidence of weight loss medications in addition to lifestyle modification supports short-term efficacy for treatment of obese children and adolescents, although long-term results remain unclear.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.